Doctors in your area are evaluating the effectiveness of an investigational medication at slowing the impact of Alzheimer’s disease on memory and daily activities when given as an intravenous (IV) infusion once every 4 weeks.

Participants can continue taking their current Alzheimer’s medications. The investigational medication, study-related evaluations, and laboratory tests will be provided to qualified participants at no cost.

To be eligible for the EXPEDITION Study, participants must:

• Be 55 years or older, and generally healthy.
• Have mild to moderate Alzheimer’s disease.
• Have a reliable caregiver (study partner) who can assist him or her during the study.

Take our study questionnaire now to see if you or your loved one pre-qualifies: